BENEFITS OF ATTENDING

4 Hours/Day

of curated content

4 Focus Areas

for all attendees – themed per day

30+ Speakers

from multiple industries

24 Sessions

led by industry leaders

What to expect at MASS

 

MASS Is the Number-One Provider of Content, Innovation, and Practical Insights for Medical Affairs Professionals!

The Medical Affairs Strategic Summit is an educational platform that provides a holistic view of medical affairs, allowing organizations to develop a unified scientific voice that will help position teams as a strategic and credible customer-facing partner in the healthcare marketplace.

This event serves as an opportunity for biotech and big pharma leadership to share insights on how the various functions within a medical organization can collaborate more effectively and develop a medical strategy that aligns with business objectives while creating a unified scientific voice that serves the patient. 
 

   Who Attends

This conference attracts SVPs, VPs, Directors, Heads and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include:

Medical Affairs

Medical Science Liaisons/Field Medical

Medical/Operations

KOL/Thought Leader Relations/Engagement

Investigator-Initiated Research (IIR)/Research Collaborations

Medical/Communications

Medical Information

Medical Education

Publication Planning

Health Economics and Outcomes Research/HEOR

Compliance/Legal

 

 

  
   Past Participants of MASS Include

AbbVie

Abiomed

Adamas Pharmaceuticals

Alcon

Amgen

Arbor Pharmaceuticals

Astellas

AveXis

Boston Scientific

Bristol-Meyers Squibb

Eli Lily

Emergent BioSolutions

EXACT Sciences

Galderma

Genentech, Inc

Gilead Science

INVIVO Communications

Kindred Biosciences, Inc.

MEI Pharma

Mitsubishi Tanabe Pharma America, Inc.

Napo Pharmaceuticals

Orchard Therapeutics

Recordati Rare Diseases, Inc

Sage Therapeutics

Sanofi

Spectranetics

Stryker Neurovascular

Takeda Pharmaceuticals

Terumo BCT, Inc.

TESARO, Inc.

United Therapeutics

Vertex Pharmaceuticals